Triad National Security (Los Alamos) (Contractor)

Triad National Security (Los Alamos) (Contractor)

Close: Dec 17, 2026

NanoFiber Engineered Therapeutics Platform (NanoFET) from Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells.

Triad National Security (Los Alamos) (Contractor)

Close: Dec 15, 2026

DC Recruiter: Broad-Spectrum Immune Enhancer from scientists at Laboratory offers a differentiated approach to multi-pathogen infection prevention by using a self-assembling peptide nanofiber to recruit and activate dendritic cells (DCs), the immune system’s natural sentinels. Unlike pathogen-specific vaccines or therapeutics, it is designed to help trigger an early immune response regardless of the infecting agent. Its needle-free, spray-friendly concept adds practicality.

Triad National Security (Los Alamos) (Contractor)

Close: Dec 15, 2026

The bacterial lipid nanodiscs platform developed by llaboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane associated targets. The platform offers a safer alternative to handling live high risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes.